King Cobra envenoming [3]

Anaesthesia

Volumn 62, Issue 10, 2007, Pages 1076-1077

  Larreche S ^a   Mion, Georges ^a   Daban, J L ^a   Goyffon, M ^b  

^a Hopital d'Instruction   (France)

^b Museum d'Histoire Naturalle   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; LABETALOL; MORPHINE; NICARDIPINE; SNAKE VENOM; SNAKE VENOM ANTISERUM; SUFENTANIL; VECURONIUM;

ANAPHYLACTIC SHOCK; ARTIFICIAL VENTILATION; BLOOD DISEASE; BRONCHOSPASM; DRUG INDICATION; ENVENOMATION; HUMAN; HYPERTENSIVE CRISIS; HYPOTENSION; HYPOVOLEMIC SHOCK; INTENSIVE CARE; LETTER; NONHUMAN; SNAKEBITE;

ANAPHYLAXIS; ANTIVENINS; COBRA VENOMS; HUMANS; SNAKE BITES;

EID: 34548629924     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05268_1.x     Document Type: Letter

References (5)

1. Veto T, Price R, Silsby JF, Carter JA. Treatment of the first known case of king cobra envenomation in the United Kingdom, complicated by severe anaphylaxis. Anaesthesia 2007; 62: 75-8.
2. Warrell DA. Treatment of bites by adders and exotic venomous snakes. British Medical Journal 2005; 331: 1244-7.
3. Chippaux JP. The development and use of immunotherapy in Africa. Toxicon 1998; 36: 1503-6.
4. Boulain JC, Menez A. Neurotoxin-specific immunoglobulins accelerate dissociation of the neurotoxin-acetylcholine receptor complex. Science 1982; 217: 732-3.
5. Trevett AJ, Lalloo D, Nwokolo NC, et al. The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni). Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89: 322-5.